Innovations In Electroporation Empower Cell-Based Therapeutic Advancement

Genetic engineering has revolutionized medicine, paving the way for groundbreaking cell-based therapies. At the heart of these treatments lies the ability to precisely modify cells. Electroporation, a technique developed in 1982 by Eberhard Neumann, has been instrumental in achieving this goal.

By applying electrical pulses, electroporation creates temporary pores in cell membranes, allowing genetic material or other molecules to enter. This efficient and non-invasive method has enabled researchers to introduce therapeutic genes into cells, correcting genetic defects and treating previously incurable diseases.

From laboratory research to commercial manufacturing, electroporation has played a vital role in advancing cell-based therapies. Its versatility and scalability make it an essential tool for scientists and clinicians working to develop innovative treatments for a wide range of conditions.